New data shows stable symptoms when switching from atypical antipsychotics to Cobenfy using cross-titration.
Harald Hampel, MD, PhD, MSc
Advertisement
Articles by Harald Hampel, MD, PhD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Psychedelics, Orexin Blockers, and More: Inside the Diverse New Pipeline for Depression
2
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
3
Expanding ADHD Pharmacology: Pipeline Highlights With Ann Childress, MD
4
Filling the Gap Between IV Ketamine Clinical Use and Evidence-Based Standards
5